Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

CT-pathologic correlation in primary hepatocellular carcinoma: an implication for target delineation.

Chen HY, Ma XM, Ye M, Hou YL, Hu B, Bai YR.

J Radiat Res. 2013 Sep;54(5):938-42. doi: 10.1093/jrr/rrt030.

2.

Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy.

Kelsey CR, Schefter T, Nash SR, Russ P, Barón AE, Zeng C, Gaspar LE.

Am J Clin Oncol. 2005 Dec;28(6):576-80.

PMID:
16317267
3.

CT and MRI in target delineation in primary hepatocellular carcinoma.

Chen HY, Hou YL, Ma XM, Xie HY, Ye M, Bai YR.

Cancer Radiother. 2013 Dec;17(8):750-4. doi: 10.1016/j.canrad.2013.05.016.

PMID:
24262499
4.

Size discrepancy between sonographic and computed tomographic/magnetic resonance imaging measurement of hepatocellular carcinoma: the necessity of tumor size measurement standardization.

Cha MJ, Lee MW, Cha DI, Kim JH, Rhim H, Cho YK, Kim YJ, Choi D, Kim YS, Lim HK.

J Ultrasound Med. 2013 Oct;32(10):1703-9. doi: 10.7863/ultra.32.10.1703.

PMID:
24065250
5.

Prediction of microvascular invasion of hepatocellular carcinoma: preoperative CT and histopathologic correlation.

Chou CT, Chen RC, Lin WC, Ko CJ, Chen CB, Chen YL.

AJR Am J Roentgenol. 2014 Sep;203(3):W253-9. doi: 10.2214/AJR.13.10595.

PMID:
25148181
6.

A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.

Park JW, Kim JH, Kim SK, Kang KW, Park KW, Choi JI, Lee WJ, Kim CM, Nam BH.

J Nucl Med. 2008 Dec;49(12):1912-21. doi: 10.2967/jnumed.108.055087.

7.

Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.

Kim SH, Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, Choi D, Lee WJ, Lim HK.

AJR Am J Roentgenol. 2009 Jun;192(6):1675-81. doi: 10.2214/AJR.08.1262.

PMID:
19457834
8.

11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective.

Cheung TT, Ho CL, Lo CM, Chen S, Chan SC, Chok KS, Fung JY, Yan Chan AC, Sharr W, Yau T, Poon RT, Fan ST.

J Nucl Med. 2013 Feb;54(2):192-200. doi: 10.2967/jnumed.112.107516.

9.

Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas.

Yoon JH, Lee EJ, Cha SS, Han SS, Choi SJ, Juhn JR, Kim MH, Lee YJ, Park SJ.

J Vasc Interv Radiol. 2010 Mar;21(3):348-56. doi: 10.1016/j.jvir.2009.11.014.

PMID:
20116285
10.

Comparison of radiographic and pathologic sizes of renal tumors.

Lee SE, Lee WK, Kim DS, Doo SH, Park HZ, Yoon CY, Hwang SI, Lee HJ, Choe G, Hong SK.

World J Urol. 2010 Jun;28(3):263-7. doi: 10.1007/s00345-010-0511-0.

PMID:
20119641
11.

Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation.

Esnaola NF, Lauwers GY, Mirza NQ, Nagorney DM, Doherty D, Ikai I, Yamaoka Y, Regimbeau JM, Belghiti J, Curley SA, Ellis LM, Vauthey JN.

J Gastrointest Surg. 2002 Mar-Apr;6(2):224-32; discussion 232.

PMID:
11992808
12.

Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.

Egger C, Goertz RS, Strobel D, Lell M, Neurath MF, Knieling F, Scharf M.

Ultraschall Med. 2012 Dec;33(6):587-92. doi: 10.1055/s-0032-1325545.

PMID:
23154871
13.

Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.

Hori T, Nagata K, Hasuike S, Onaga M, Motoda M, Moriuchi A, Iwakiri H, Uto H, Kato J, Ido A, Hayashi K, Tsubouchi H.

J Gastroenterol. 2003;38(10):977-81.

PMID:
14614605
14.

Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin.

Nakazawa T, Kokubu S, Shibuya A, Ono K, Watanabe M, Hidaka H, Tsuchihashi T, Saigenji K.

AJR Am J Roentgenol. 2007 Feb;188(2):480-8.

PMID:
17242258
15.

MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation.

Burrel M, Llovet JM, Ayuso C, Iglesias C, Sala M, Miquel R, Caralt T, Ayuso JR, Solé M, Sanchez M, Brú C, Bruix J; Barcelona Clínic Liver Cancer Group..

Hepatology. 2003 Oct;38(4):1034-42.

PMID:
14512891
16.

[Evaluation of noninvasive diagnostic criteria for hepatocellular carcinoma on pretransplant MRI (2010): correlation between MR imaging features and histological features on liver specimen].

Ouedraogo W, Tran-Van Nhieu J, Baranes L, Lin SJ, Decaens T, Laurent A, Djabbari M, Pigneur F, Duvoux C, Kobeiter H, Deux JF, Rahmouni A, Luciani A.

J Radiol. 2011 Jul-Aug;92(7-8):688-700. doi: 10.1016/j.jradio.2011.03.020. French.

17.

Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.

Yu MH, Kim JH, Yoon JH, Kim HC, Chung JW, Han JK, Choi BI.

Radiology. 2014 Jun;271(3):748-60. doi: 10.1148/radiol.14131996.

PMID:
24588677
18.

Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging--comparison to prior same-center results after MR systems improvements.

Becker-Weidman DJ, Kalb B, Sharma P, Kitajima HD, Lurie CR, Chen Z, Spivey JR, Knechtle SJ, Hanish SI, Adsay NV, Farris AB 3rd, Martin DR.

Radiology. 2011 Dec;261(3):824-33. doi: 10.1148/radiol.11110157.

PMID:
21969663
19.

Contrast-enhanced ultrasound in the characterization of hepatocellular carcinomas treated by ablation: comparison with contrast-enhanced magnetic resonance imaging.

Qu P, Yu X, Liang P, Cheng Z, Han Z, Liu F, Yu J.

Ultrasound Med Biol. 2013 Sep;39(9):1571-9. doi: 10.1016/j.ultrasmedbio.2013.03.030.

PMID:
23830098
20.

Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma.

Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, Yamaoka Y, Belghiti J, Lauwers GY, Poon RT, Abdalla EK.

Liver Transpl. 2005 Sep;11(9):1086-92.

Supplemental Content

Support Center